India's Aurobindo Pharma leads race to buy generic drugmaker Zentiva for $5.5 billion, Economic Times reports – Reuters

1. India’s Aurobindo Pharma leads race to buy generic drugmaker Zentiva for $5.5 billion, Economic Times reports  Reuters
2. Aurobindo Pharma closing in on $5.5b Zentiva buyout  The Economic Times
3. Aurobindo Pharma shares tumble almost 5% on reports of Zentiva acquisition bid; company issues clarification  Mint
4. India’s Aurobindo Pharma recoups losses after saying no binding agreement for Zentiva  TradingView
5. Aurobindo Pharma clarifies, reports of Zentiva buyout ‘premature’, no binding agreement yet  Moneycontrol

Continue Reading